Christopher Raymond

Chris Raymond is a managing director and senior research analyst at Piper Sandler covering the biotechnology sector. Prior to joining Piper, he spent the previous 17 years covering biotechnology at Raymond James, Robert W. Baird and Prudential Vector Healthcare Group. Before that, he spent 10 years with Baxter Healthcare and G. D. Searle in various marketing, business development and strategy roles. Raymond has been recognized twice by StarMine as a top earnings estimator in biotechnology and in 2004 was recognized byThe Wall Street Journal "Best on the Street" survey. Raymond received his bachelor’s degree from Michigan State University and his Master of Business Administration degree from the University of Chicago Graduate School of Business. He currently serves on the board of the Financial Markets Institute at Michigan State's Broad College of Business.

Universe Coverage

Biotechnology
ABBV	AbbVie Inc.
ABVX	Abivax SA
ACRS	Aclaris Therapeutics, Inc.
AGIO	Agios Pharmaceuticals, Inc.
ALVR	AlloVir, Inc.
ALXO	ALX Oncology Holdings, Inc.
AMGN	Amgen Inc.
ARDX	Ardelyx, Inc.
BCRX	BioCryst Pharmaceuticals, Inc.
BIIB	Biogen Inc.
BHVN	Biohaven Ltd.
BMRN	BioMarin Pharmaceutical Inc.
BPMC	Blueprint Medicines Corporation
COGT	Cogent Biosciences, Inc.
INZY	Inozyme Pharma, Inc.
IOBT	IO Biotech, Inc.
ITOS	iTeos Therapeutics, Inc.
KPTI	Karyopharm Therapeutics, Inc.
MGTX	MeiraGTx Holdings Plc
NUVL	Nuvalent, Inc.
QTTB	Q32 Bio, Inc.
REGN	Regeneron Pharmaceuticals Inc.
TSHA	Taysha Gene Therapies, Inc.
TYRA	Tyra Biosciences, Inc.
RARE	Ultragenyx Pharmaceutical, Inc.
VRTX	Vertex Pharmaceuticals Inc.